{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:58:32Z","timestamp":1772121512032,"version":"3.50.1"},"reference-count":105,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006510","name":"Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.pbb.2022.173485","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T18:43:33Z","timestamp":1666637013000},"page":"173485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Rapastinel accelerates loss of withdrawal signs after repeated morphine and blunts relapse to conditioned place preference"],"prefix":"10.1016","volume":"221","author":[{"given":"Christopher","family":"Armstrong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidesh","family":"Lamichhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zachery","family":"Reavis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwin","family":"Patkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.pbb.2022.173485_bb0005","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.brainresrev.2008.08.002","article-title":"Neurobiological mechanisms of the reinstatement of drug-conditioned place preference","volume":"59","author":"Aguilar","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"4","key":"10.1016\/j.pbb.2022.173485_bb0010","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0893-133X(99)00133-5","article-title":"Persistent increase in the motivation to take heroin in rats with a history of drug escalation","volume":"22","author":"Ahmed","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2022.173485_bb0015","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuroscience.2012.04.032","article-title":"Morphine and MK-801 administration leads to alternative N-methyl-D-aspartate receptor 1 splicing and associated changes in reward seeking behavior and nociception on an operant orofacial assay","volume":"214","author":"Anderson","year":"2012","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1124\/jpet.115.227629","article-title":"Phosphorylation of the N-methyl-d-aspartate receptor is increased in the nucleus accumbens during both acute and extended morphine withdrawal","volume":"355","author":"Anderson","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.pbb.2022.173485_bb0025","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/jnr.20756","article-title":"Chronic morphine treatment alters expression of N-methyl-D-aspartate receptor subunits in the extended amygdala","volume":"83","author":"Bajo","year":"2006","journal-title":"J. Neurosci. Res."},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0091-3057(97)00596-0","article-title":"Neonatal withdrawal following pre- and postnatal exposure to methadone in the rat","volume":"60","author":"Barr","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/ilar.52.3.329","article-title":"Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience","volume":"52","author":"Barr","year":"2011","journal-title":"ILAR J."},{"issue":"5","key":"10.1016\/j.pbb.2022.173485_bb0040","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jsat.2014.01.005","article-title":"A placebo-controlled trial of memantine as an adjunct to injectable extended-release naltrexone for opioid dependence","volume":"46","author":"Bisaga","year":"2014","journal-title":"J. Subst. Abus. Treat."},{"issue":"4","key":"10.1016\/j.pbb.2022.173485_bb0045","doi-asserted-by":"crossref","first-page":"484","DOI":"10.15288\/jsad.2020.81.484","article-title":"Nonmedical use of prescription opioids, heroin use, injection drug use, and overdose mortality in U.S. adolescents","volume":"81","author":"Bohm","year":"2020","journal-title":"J. Stud. Alcohol Drugs"},{"issue":"4","key":"10.1016\/j.pbb.2022.173485_bb0050","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.neurobiolaging.2009.04.012","article-title":"The N-methyl-D-aspartate receptor modulator GLYX-13 enhances learning and memory, in young adult and learning impaired aging rats","volume":"32","author":"Burgdorf","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.pbb.2022.173485_bb0055","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.neuroscience.2011.05.001","article-title":"Positive emotional learning is regulated in the medial prefrontal cortex by GluN2B-containing NMDA receptors","volume":"192","author":"Burgdorf","year":"2011","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.pbb.2022.173485_bb0060","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/npp.2012.246","article-title":"GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects","volume":"38","author":"Burgdorf","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2022.173485_bb0065","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuroscience.2015.09.004","article-title":"The long-lasting antidepressant effects of rapastinel (GLYX-13) are associated with a metaplasticity process in the medial prefrontal cortex and hippocampus","volume":"308","author":"Burgdorf","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2022.173485_bb0070","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbr.2015.07.039","article-title":"Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats","volume":"294","author":"Burgdorf","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.pbb.2022.173485_bb0075","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-3565(24)34977-8","article-title":"Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal","volume":"290","author":"Caille","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2022.173485_bb0080","article-title":"Adolescent oxycodone exposure inhibits withdrawal-induced expression of genes associated with the dopamine transmission","author":"Carpenter","year":"2020","journal-title":"Addict. Biol."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s002130000413","article-title":"Opiate withdrawal in the neonatal rat: relationship to duration of treatment and naloxone dose","volume":"150","author":"Ceger","year":"2000","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0091-3057(99)00174-4","article-title":"Gender differences in the reinforcing properties of morphine","volume":"65","author":"Cicero","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0095","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0091-3057(02)00740-2","article-title":"Gender-linked differences in the expression of physical dependence in the rat","volume":"72","author":"Cicero","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0091-3057(02)01039-0","article-title":"Gender differences in the intravenous self-administration of mu opiate agonists","volume":"74","author":"Cicero","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050911","article-title":"Sex differences in development of morphine tolerance and dependence in the rat","volume":"143","author":"Craft","year":"1999","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.pbb.2022.173485_bb0110","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.biopsych.2012.05.030","article-title":"Maintaining clinical relevance: considerations for the future of research into D-cycloserine and cue exposure therapy for addiction","volume":"72","author":"Das","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0115","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00213-012-2847-1","article-title":"Attenuated effects of experimenter-administered heroin in adolescent vs. adult male rats: physical withdrawal and locomotor sensitization","volume":"225","author":"Doherty","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/ijnp\/pyy101","article-title":"Positive N-methyl-D-aspartate receptor modulation by rapastinel promotes rapid and sustained antidepressant-like effects","volume":"22","author":"Donello","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2022.173485_bb0125","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ibror.2019.01.001","article-title":"The emergence of new antidepressants for clinical use: agomelatine paradox versus other novel agents","volume":"6","author":"Fasipe","year":"2019","journal-title":"IBRO Rep."},{"key":"10.1016\/j.pbb.2022.173485_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107845","article-title":"Clinical benefits and risks of N-methyl-D-aspartate receptor antagonists to treat severe opioid use disorder: a systematic review","author":"Fluyau","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.pbb.2022.173485_bb0135","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.pcl.2019.08.005","article-title":"Prescription opioid misuse among adolescents","volume":"66","author":"Ford","year":"2019","journal-title":"Pediatr. Clin. N. Am."},{"issue":"7","key":"10.1016\/j.pbb.2022.173485_bb0140","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1046\/j.1460-9568.2002.02187.x","article-title":"Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal","volume":"16","author":"Frenois","year":"2002","journal-title":"Eur. J. Neurosci."},{"issue":"14","key":"10.1016\/j.pbb.2022.173485_bb0145","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/jama.2022.2847","article-title":"Trends in drug overdose deaths among US adolescents, january 2010 to june 2021","volume":"327","author":"Friedman","year":"2022","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pbb.2022.173485_bb0150","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/14737175.2017.1283217","article-title":"Investigational drugs in recent clinical trials for treatment-resistant depression","volume":"17","author":"Garay","year":"2017","journal-title":"Expert. Rev. Neurother."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0155","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-3565(25)31261-9","article-title":"Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions","volume":"205","author":"Gellert","year":"1978","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0160","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1124\/jpet.118.249409","article-title":"NYX-2925 is a novel N-methyl-d-aspartate receptor modulator that induces rapid and long-lasting analgesia in rat models of neuropathic pain","volume":"366","author":"Ghoreishi-Haack","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0165","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s00213-019-05403-z","article-title":"Spermidine, a positive modulator of the NMDA receptor, facilitates extinction and prevents the reinstatement of morphine-induced conditioned place preference in mice","volume":"237","author":"Girardi","year":"2020","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1471-4159.1991.tb02131.x","article-title":"Glycine-like modulation of N-methyl-D-aspartate receptors by a monoclonal antibody that enhances long-term potentiation","volume":"57","author":"Haring","year":"1991","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0175","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.tips.2017.12.004","article-title":"Opioid and psychostimulant plasticity: targeting overlap in nucleus accumbens glutamate signaling","volume":"39","author":"Hearing","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2022.173485_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107985","article-title":"Cross-generational THC exposure alters heroin reinforcement in adult male offspring","volume":"212","author":"Hempel","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/da.22257","article-title":"D-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse","volume":"31","author":"Hofmann","year":"2014","journal-title":"Depress Anxiety."},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0190","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/gbb.12348","article-title":"Do specific NMDA receptor subunits act as gateways for addictive behaviors?","volume":"16","author":"Hopf","year":"2017","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.pbb.2022.173485_bb0195","first-page":"466","article-title":"Glutamatergic synaptic plasticity in the mesocorticolimbic system in addiction","volume":"8","author":"van Huijstee","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"4 Suppl","key":"10.1016\/j.pbb.2022.173485_bb0200","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00002508-200207001-00002","article-title":"Clinical pharmacology of opioids for pain","volume":"18","author":"Inturrisi","year":"2002","journal-title":"Clin. J. Pain"},{"issue":"7\u20138","key":"10.1016\/j.pbb.2022.173485_bb0205","first-page":"435","article-title":"Pharmacology of methadone and its isomers","volume":"71","author":"Inturrisi","year":"2005","journal-title":"Minerva Anestesiol."},{"key":"10.1016\/j.pbb.2022.173485_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134625","article-title":"Adolescent morphine induces emotional signs of withdrawal paired with neurotoxicity selectively in male rats: female resilience","volume":"715","author":"Jim\u00e9nez-Romero","year":"2020","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.pbb.2022.173485_bb0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1037\/pha0000306","article-title":"Randomized controlled trial of d-cycloserine in cocaine dependence: effects on contingency management and cue-induced cocaine craving in a naturalistic setting","volume":"28","author":"Johnson","year":"2020","journal-title":"Exp. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0220","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/sj.npp.1301564","article-title":"Drug addiction as a pathology of staged neuroplasticity","volume":"33","author":"Kalivas","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2022.173485_bb0225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pbb.2017.03.007","article-title":"Depression of home cage wheel running is an objective measure of spontaneous morphine withdrawal in rats with and without persistent pain","volume":"156","author":"Kandasamy","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1\u20133","key":"10.1016\/j.pbb.2022.173485_bb0230","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejphar.2007.12.010","article-title":"Morphine sex-dependently induced place conditioning in adult wistar rats","volume":"582","author":"Karami","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.pbb.2022.173485_bb0235","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1037\/0735-7044.104.5.704","article-title":"Context-specific morphine withdrawal in rats: duration and effects of clonidine","volume":"104","author":"Kelsey","year":"1990","journal-title":"Behav. Neurosci."},{"issue":"11","key":"10.1016\/j.pbb.2022.173485_bb0240","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.biopsych.2018.02.009","article-title":"Animal models of addiction and neuropsychiatric disorders and their role in drug discovery: honoring the legacy of athina markou","volume":"83","author":"Kenny","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2022.173485_bb0245","article-title":"NYX-2925 is a novel NMDA receptor-specific spirocyclic-beta-lactam that modulates synaptic plasticity processes associated with learning and memory","author":"Khan","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"11","key":"10.1016\/j.pbb.2022.173485_bb0250","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s00213-014-3695-y","article-title":"Morphine-induced conditioned place preference and effects of morphine pre-exposure in adolescent and adult male C57BL\/6J mice","volume":"233","author":"Koek","year":"2016","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0255","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biopsych.2019.05.023","article-title":"Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement","volume":"87","author":"Koob","year":"2020","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0260","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pharmrev.120.000083","article-title":"Drug addiction: hyperkatifeia\/negative reinforcement as a framework for medications development","volume":"73","author":"Koob","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"8","key":"10.1016\/j.pbb.2022.173485_bb0265","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S2215-0366(16)00104-8","article-title":"Neurobiology of addiction: a neurocircuitry analysis","volume":"3","author":"Koob","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"4","key":"10.1016\/j.pbb.2022.173485_bb0270","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0091-3057(80)90199-9","article-title":"Physical dependence and tolerance development after chronic exposure to low levels of morphine in the rat","volume":"12","author":"Kosersky","year":"1980","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"4","key":"10.1016\/j.pbb.2022.173485_bb0275","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0893-133X(95)00065-L","article-title":"The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist","volume":"13","author":"Kosten","year":"1995","journal-title":"Neuropsychopharmacology"},{"issue":"Pt 1","key":"10.1016\/j.pbb.2022.173485_bb0280","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainresbull.2016.05.016","article-title":"Ketamine abuse potential and use disorder","volume":"126","author":"Liu","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0285","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neulet.2011.08.034","article-title":"Effects of D-cycloserine on extinction and reinstatement of morphine-induced conditioned place preference","volume":"503","author":"Lu","year":"2011","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0290","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s002130050979","article-title":"Sex differences in the acquisition of intravenously self-administered cocaine and heroin in rats","volume":"144","author":"Lynch","year":"1999","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.pbb.2022.173485_bb0295","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/0269881120926675","article-title":"Pre-exposure of adolescent mice to morphine results in stronger sensitization and reinstatement of conditioned place preference than pre-exposure to hydrocodone","volume":"34","author":"Madison","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2022.173485_bb0300","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5055\/jom.2020.0560","article-title":"An overview on medication-assisted treatment (MAT) for opioid dependence","volume":"16","author":"Maiti","year":"2020","journal-title":"J. Opioid Manag."},{"issue":"10","key":"10.1016\/j.pbb.2022.173485_bb0305","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/archpsyc.62.10.1157","article-title":"Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial","volume":"62","author":"Marsch","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"issue":"8","key":"10.1016\/j.pbb.2022.173485_bb0310","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/add.13363","article-title":"A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults","volume":"111","author":"Marsch","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2022.173485_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2020.582147","article-title":"Drug-induced conditioned place preference and its practical use in substance use disorder research","volume":"14","author":"McKendrick","year":"2020","journal-title":"Front. Behav. Neurosci."},{"issue":"25","key":"10.1016\/j.pbb.2022.173485_bb0320","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1056\/NEJMra1600879","article-title":"Neonatal abstinence syndrome","volume":"375","author":"McQueen","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"15","key":"10.1016\/j.pbb.2022.173485_bb0325","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1007\/s00213-015-3913-2","article-title":"Effect of ceftriaxone and topiramate treatments on naltrexone-precipitated morphine withdrawal and glutamate receptor desensitization in the rat locus coeruleus","volume":"232","author":"Medrano","year":"2015","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.pbb.2022.173485_bb0330","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.neuropharm.2005.06.006","article-title":"GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator","volume":"49","author":"Moskal","year":"2005","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2022.173485_bb0335","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/13543784.2014.852536","article-title":"GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists","volume":"23","author":"Moskal","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0340","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2174\/1570159X14666160321122703","article-title":"The development of rapastinel (Formerly GLYX-13); a rapid acting and long lasting antidepressant","volume":"15","author":"Moskal","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2022.173485_bb0345","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0166-4328(02)00297-8","article-title":"Persistence and drug-induced reinstatement of a morphine-induced conditioned place preference","volume":"136","author":"Mueller","year":"2002","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0350","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejphar.2007.01.027","article-title":"Nucleus accumbens NMDA receptor subunit expression and function is enhanced in morphine-dependent rats","volume":"562","author":"Murray","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0355","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopsych.2009.08.015","article-title":"D-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats","volume":"67","author":"Myers","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pbb.2022.173485_bb0360","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neubiorev.2010.01.011","article-title":"Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction","volume":"35","author":"Myers","year":"2010","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2022.173485_bb0365","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.brainres.2015.12.039","article-title":"Reflections on: \"A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function\"","volume":"1645","author":"Nestler","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2022.173485_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.nlm.2018.02.007","article-title":"Metaplasticity at the addicted tetrapartite synapse: a common denominator of drug induced adaptations and potential treatment target for addiction","author":"Neuhofer","year":"2018","journal-title":"Neurobiol. Learn. Mem."},{"issue":"10","key":"10.1016\/j.pbb.2022.173485_bb0375","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.pbb.2022.173485_bb0380","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1023\/A:1026618603795","article-title":"Modulation of NMDA receptor subunit mRNA in butorphanol-tolerant and -withdrawing rats","volume":"25","author":"Oh","year":"2000","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0385","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/sj.npp.1300760","article-title":"Reinstatement of morphine-conditioned reward is blocked by memantine","volume":"31","author":"Popik","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.pbb.2022.173485_bb0390","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.drugalcdep.2013.02.009","article-title":"Impact of DCS-facilitated cue exposure therapy on brain activation to cocaine cues in cocaine dependence","volume":"132","author":"Prisciandaro","year":"2013","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/j.pbb.2022.173485_bb0395","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0893-133X(95)00082-O","article-title":"The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal","volume":"13","author":"Rasmussen","year":"1995","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.pbb.2022.173485_bb0400","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1523\/JNEUROSCI.10-07-02308.1990","article-title":"Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates","volume":"10","author":"Rasmussen","year":"1990","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0405","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-2999(91)90358-W","article-title":"NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal","volume":"197","author":"Rasmussen","year":"1991","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0410","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/syn.890200110","article-title":"NMDA antagonists and clonidine block c-fos expression during morphine withdrawal","volume":"20","author":"Rasmussen","year":"1995","journal-title":"Synapse"},{"issue":"2","key":"10.1016\/j.pbb.2022.173485_bb0415","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/FBP.0b013e328337be10","article-title":"Beta-lactam antibiotic inhibits development of morphine physical dependence in rats","volume":"21","author":"Rawls","year":"2010","journal-title":"Behav. Pharmacol."},{"issue":"6","key":"10.1016\/j.pbb.2022.173485_bb0420","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.brainresbull.2004.10.005","article-title":"NMDA glutamate but not dopamine antagonists blocks drug-induced reinstatement of morphine place preference","volume":"64","author":"Ribeiro Do Couto","year":"2005","journal-title":"Brain Res. Bull."},{"issue":"23\u201324","key":"10.1016\/j.pbb.2022.173485_bb0425","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1007\/s00213-016-4425-4","article-title":"Long-lasting effects of adolescent oxycodone exposure on reward-related behavior and gene expression in mice","volume":"233","author":"Sanchez","year":"2016","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0430","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/ajad.12191","article-title":"D-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependence","volume":"24","author":"Santa Ana","year":"2015","journal-title":"Am. J. Addict."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0435","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00213-011-2216-5","article-title":"Role of individual and developmental differences in voluntary cocaine intake in rats","volume":"215","author":"Schramm-Sapyta","year":"2011","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0440","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsat.2014.04.006","article-title":"Emerging adult age status predicts poor buprenorphine treatment retention","volume":"47","author":"Schuman-Olivier","year":"2014","journal-title":"J. Subst. Abus. Treat."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0445","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1124\/pr.116.012484","article-title":"The nucleus accumbens: mechanisms of addiction across drug classes reflect the importance of glutamate homeostasis","volume":"68","author":"Scofield","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.pbb.2022.173485_bb0450","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/cap.2019.0009","article-title":"Pharmacological treatment of youth substance use disorders","volume":"29","author":"Squeglia","year":"2019","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"13","key":"10.1016\/j.pbb.2022.173485_bb0455","first-page":"1193","article-title":"Neuroprotection by a novel NMDAR functional glycine site partial agonist, GLYX-13","volume":"20","author":"Stanton","year":"2009"},{"issue":"1","key":"10.1016\/j.pbb.2022.173485_bb0460","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/FBP.0b013e3283359f39","article-title":"Peri, pre and postnatal morphine exposure: exposure-induced effects and sex differences in the behavioural consequences in rat offspring","volume":"21","author":"Timar","year":"2010","journal-title":"Behav. Pharmacol."},{"issue":"2","key":"10.1016\/j.pbb.2022.173485_bb0465","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/ph6020251","article-title":"NMDA receptor modulators in the treatment of drug addiction","volume":"6","author":"Tomek","year":"2013","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pbb.2022.173485_bb0470","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuropharm.2019.03.019","article-title":"Male and female mice develop escalation of heroin intake and dependence following extended access","volume":"151","author":"Towers","year":"2019","journal-title":"Neuropharmacology"},{"issue":"4989","key":"10.1016\/j.pbb.2022.173485_bb0475","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1126\/science.1824728","article-title":"Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801","volume":"251","author":"Trujillo","year":"1991","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.pbb.2022.173485_bb0480","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/npp.2016.287","article-title":"Incubation of methamphetamine but not heroin craving after voluntary abstinence in male and female rats","volume":"42","author":"Venniro","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.pbb.2022.173485_bb0485","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1159\/000139017","article-title":"Pharmacodynamics and kinetics of loss of tolerance and physical dependence on morphine induced by pellet implantation in the rat","volume":"45","author":"Villar","year":"1992","journal-title":"Pharmacology"},{"issue":"5","key":"10.1016\/j.pbb.2022.173485_bb0490","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ntt.2008.04.002","article-title":"Cocaine increases stimulated dopamine release more in periadolescent than adult rats","volume":"30","author":"Walker","year":"2008","journal-title":"Neurotoxicol. Teratol."},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0495","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.pbb.2008.08.019","article-title":"Novelty-induced locomotion is positively associated with cocaine ingestion in adolescent rats; anxiety is correlated in adults","volume":"91","author":"Walker","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2022.173485_bb0500","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bbrc.2022.01.024","article-title":"Glutamatergic receptor and neuroplasticity in depression: implications for ketamine and rapastinel as the rapid-acting antidepressants","volume":"594","author":"Wang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.pbb.2022.173485_bb0505","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.drudis.2018.11.007","article-title":"A new generation of antidepressants: an update on the pharmaceutical pipeline for novel and rapid-acting therapeutics in mood disorders based on glutamate\/GABA neurotransmitter systems","volume":"24","author":"Wilkinson","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.pbb.2022.173485_bb0510","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0022-3565(25)09656-9","article-title":"The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies","volume":"273","author":"Windh","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.pbb.2022.173485_bb0515","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s00213-002-1190-3","article-title":"Blockade of ionotropic glutamatergic transmission in the ventral tegmental area reduces heroin reinforcement in rat","volume":"164","author":"Xi","year":"2002","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2022.173485_bb0520","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0022-3565(25)23967-2","article-title":"Pharmacokinetics and pharmacodynamics of subcutaneous morphine pellets in the rat","volume":"235","author":"Yoburn","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"7","key":"10.1016\/j.pbb.2022.173485_bb0525","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.neuropharm.2008.08.018","article-title":"A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at schaffer collateral-CA1 synapses in hippocampus","volume":"55","author":"Zhang","year":"2008","journal-title":"Neuropharmacology"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305722001642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305722001642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:44:44Z","timestamp":1758775484000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305722001642"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":105,"alternative-id":["S0091305722001642"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2022.173485","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.08.19.504553","asserted-by":"object"}]},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapastinel accelerates loss of withdrawal signs after repeated morphine and blunts relapse to conditioned place preference","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2022.173485","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"173485"}}